Developmental origins of nonalcoholic fatty liver disease

David E Brumbaugh1, Jacob E Friedman2

  • 1Department of Pediatrics, University of Colorado School of Medicine, Aurora, Colorado.

Pediatric Research
|November 7, 2013
PubMed

Insights

Maternal obesity can lead to generational nonalcoholic fatty liver disease (NAFLD) in offspring. This occurs through metabolic programming and epigenetic changes, increasing NAFLD risk across generations.

Area of Science:

  • Reproductive biology
  • Metabolic disorders
  • Hepatology

Background:

  • Maternal obesity poses risks for offspring metabolic health.
  • Early childhood obesity is a predictor for nonalcoholic fatty liver disease (NAFLD).
  • Fetal vulnerability to steatosis is heightened by immature adipose depots in maternal obesity.

Purpose of the Study:

  • To investigate the intergenerational transmission of metabolic phenotypes from obese mothers to offspring.
  • To explore the mechanisms by which maternal obesity primes offspring liver for NAFLD development.
  • To examine the role of in utero exposure and epigenetic factors in NAFLD predisposition.

Main Methods:

  • Review of animal models demonstrating effects of in utero high-fat diet exposure on offspring liver.
  • Analysis of human studies correlating maternal BMI with infant intrahepatocellular lipid storage.
  • Exploration of potential epigenetic and microbiota-mediated transmission pathways.

Main Results:

  • In utero high-fat diet exposure in animal models increases offspring liver triglycerides, oxidative stress, and apoptosis.
  • Postweaning offspring livers exhibit NAFLD-like features, including altered lipogenesis and fatty acid oxidation.
  • Human studies confirm maternal BMI predicts infant liver lipid accumulation.

Conclusions:

  • Maternal obesity can program offspring for NAFLD through metabolic and epigenetic changes.
  • The generational transfer of NAFLD risk is influenced by in utero environment and potentially microbiota.
  • Early life interventions may be crucial to mitigate intergenerational NAFLD transmission.

Related Concept Videos

Chronic Pancreatitis I: Introduction01:25

Chronic Pancreatitis I: Introduction

Chronic pancreatitis is a long-standing, relapsing inflammation of the pancreas, characterized by irreversible damage to the gland. It results in progressive destruction of the pancreatic parenchyma, fibrosis, and eventual loss of both exocrine and endocrine function. The disease may evolve gradually after multiple episodes of acute pancreatitis or develop independently.EtiologyChronic pancreatitis can arise from a variety of causes:Alcohol use is the leading cause, accounting for 70–80%...
29
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
918
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
32
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
2.1K
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
57
Chronic Pancreatitis II: Pathophysiology01:21

Chronic Pancreatitis II: Pathophysiology

Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
36